Duke Scientists Identify Lung Cancer Biomarker
Radiologists at the Duke University Medical Center said they have used MALDI-TOF to isolate and identify a known serum biomarker for lung cancer. The marker, serum amyloid A, is elevated in patients with the disease. The study was published in the Sept. issue of Proteomics. The Duke researchers are describing the study as a proof of principle that MALDI can be used effectively to both find and identify disease biomarkers.